Dustin Sjuts
2020
In 2020, Dustin Sjuts earned a total compensation of $3.2M as Chief Commercial Officer at Revance Therapeutics, a 302% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $141,020 |
|---|---|
| Option Awards | $1,306,320 |
| Salary | $415,000 |
| Stock Awards | $1,294,250 |
| Other | $66,242 |
| Total | $3,222,832 |
Sjuts received $1.3M in option awards, accounting for 41% of the total pay in 2020.
Sjuts also received $141K in non-equity incentive plan, $415K in salary, $1.3M in stock awards and $66.2K in other compensation.
Rankings
In 2020, Dustin Sjuts' compensation ranked 3,613th out of 13,090 executives tracked by ExecPay. In other words, Sjuts earned more than 72.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,613 out of 13,090 | 72nd |
Division Manufacturing | 1,416 out of 5,620 | 75th |
Major group Chemicals And Allied Products | 532 out of 2,253 | 76th |
Industry group Drugs | 462 out of 1,953 | 76th |
Industry Pharmaceutical Preparations | 348 out of 1,458 | 76th |
Pay ratio
| Dustin Sjuts' Pay | $3,222,832 |
|---|---|
| Median Employee's Pay | $254,090 |
| Pay Ratio | 13to 1 |
In 2020, the annual total compensation of Dustin Sjuts was $3,222,832.
The annual total compensation of the median employee at Revance Therapeutics was $254,090.
The ratio of Dustin Sjuts' pay to the pay of median employee was therefore 13 to one.
Source: SEC filing on March 24, 2021.
Sjuts' colleagues
We found four more compensation records of executives who worked with Dustin Sjuts at Revance Therapeutics in 2020.